BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22876334)

  • 1. What's New in Transarterial Therapies for Hepatocellular Carcinoma?
    May BJ; Murthy R; Madoff DC
    Gastrointest Cancer Res; 2012 May; 5(3 Suppl 1):S14-9. PubMed ID: 22876334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraarterial Therapies for the Management of Hepatocellular Carcinoma.
    Garg T; Shrigiriwar A; Habibollahi P; Cristescu M; Liddell RP; Chapiro J; Inglis P; Camacho JC; Nezami N
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New concepts in embolotherapy of HCC.
    Pesapane F; Nezami N; Patella F; Geschwind JF
    Med Oncol; 2017 Apr; 34(4):58. PubMed ID: 28299645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transarterial chemoembolization, transarterial chemotherapy, and intra-arterial chemotherapy for hepatocellular carcinoma treatment.
    Tsochatzis EA; Germani G; Burroughs AK
    Semin Oncol; 2010 Apr; 37(2):89-93. PubMed ID: 20494700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HCC: Transarterial Therapies-What the Interventional Radiologist Can Offer.
    Vogl TJ; Gruber-Rouh T
    Dig Dis Sci; 2019 Apr; 64(4):959-967. PubMed ID: 30835030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transarterial therapies for hepatocellular carcinoma.
    Sangro B; D'Avola D; IƱarrairaegui M; Prieto J
    Expert Opin Pharmacother; 2011 May; 12(7):1057-73. PubMed ID: 21470073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoembolization of hepatocellular carcinoma with drug-eluting beads complicated by interstitial pneumonitis.
    Aladdin M; Ilyas M
    Semin Intervent Radiol; 2011 Jun; 28(2):218-21. PubMed ID: 22654266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial Therapies for Hepatocellular Carcinoma: a Comprehensive Review with Current Updates and Future Directions.
    Kumar Y; Sharma P; Bhatt N; Hooda K
    Asian Pac J Cancer Prev; 2016; 17(2):473-8. PubMed ID: 26925630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transvascular therapy of Hepatocellular Carcinoma (HCC), status and developments.
    Gnutzmann D; Kortes N; Sumkauskaite M; Schmitz A; Weiss KH; Radeleff B
    Minim Invasive Ther Allied Technol; 2018 Apr; 27(2):69-80. PubMed ID: 29381102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transarterial chemoembolization and yittrium-90 for liver cancer and other lesions.
    Minocha J; Salem R; Lewandowski RJ
    Clin Liver Dis; 2014 Nov; 18(4):877-90. PubMed ID: 25438288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial.
    Seinstra BA; Defreyne L; Lambert B; Lam MG; Verkooijen HM; van Erpecum KJ; van Hoek B; van Erkel AR; Coenraad MJ; Al Younis I; van Vlierberghe H; van den Bosch MA
    Trials; 2012 Aug; 13():144. PubMed ID: 22913492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermediate hepatocellular carcinoma: the role of transarterial therapy.
    Chegai F; Orlacchio A; Merolla S; Monti S; Mannelli L
    Hepat Oncol; 2015 Oct; 2(4):399-408. PubMed ID: 26998220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraperitoneal metastases after transarterial embolization of hepatocellular carcinoma: An observational study.
    Meier JM; Behr SC; Jordan E; Pallav Kolli K; Yeh BM
    Abdom Radiol (NY); 2017 Jun; 42(6):1794-1798. PubMed ID: 28197682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transarterial chemoembolization for primary liver malignancies and colorectal liver metastasis.
    Miura JT; Gamblin TC
    Surg Oncol Clin N Am; 2015 Jan; 24(1):149-66. PubMed ID: 25444473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoembolization and radioembolization for hepatocellular carcinoma.
    Salem R; Lewandowski RJ
    Clin Gastroenterol Hepatol; 2013 Jun; 11(6):604-11; quiz e43-4. PubMed ID: 23357493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transarterial ablation of hepatocellular carcinoma. Status and developments].
    Radeleff BA; Stampfl U; Sommer CM; Bellemann N; Hoffmann K; Ganten T; Ehehalt R; Kauczor HU
    Radiologe; 2012 Jan; 52(1):44-55. PubMed ID: 22249701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced ultrasound evaluation of residual blood flow to hepatocellular carcinoma after treatment with transarterial chemoembolization using drug-eluting beads: a prospective study.
    Shaw CM; Eisenbrey JR; Lyshchik A; O'Kane PL; Merton DA; Machado P; Pino L; Brown DB; Forsberg F
    J Ultrasound Med; 2015 May; 34(5):859-67. PubMed ID: 25911704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transarterial chemoembolization and radioembolization.
    Sangro B; Salem R
    Semin Liver Dis; 2014 Nov; 34(4):435-43. PubMed ID: 25369305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current locoregional therapies and treatment strategies in hepatocellular carcinoma.
    Cardarelli-Leite L; Hadjivassiliou A; Klass D; Chung J; Ho SGF; Lim HJ; Kim PTW; Mujoomdar A; Liu DM
    Curr Oncol; 2020 Nov; 27(Suppl 3):S144-S151. PubMed ID: 33343208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transarterial Chemoembolization and (90)Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease.
    Fidelman N; Kerlan RK
    AJR Am J Roentgenol; 2015 Oct; 205(4):742-52. PubMed ID: 26397322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.